newsfilter
← Latest News
Business Wire·

Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer

Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced the appointment of Adam Muzikant, PhD, as Chief Business Officer. Dr. Muzikant brings 18 years of business development experience creating and